Yoshinori Tamada

Prof. Yoshinori Tamada

Hirosaki University, Hirosaki, Japan
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2002 in Bioinformatics
Verified
Journal Article
Open access
PDF file
HBHideo Bannai
Hideo Bannai
YTYoshinori Tamada
Yoshinori Tamada
OMOsamu Maruyama
Osamu Maruyama
KNKenta Nakai
Kenta Nakai
SMSatoru Miyano
Satoru Miyano
Motivation: The prediction of localization sites of various proteins is an important and challenging problem in the field of molecular biology. TargetP, by Emanuelsson et al. (J. Mol. Biol. , 300, 1005–1016, 2000) is a neural network based system which is currently the best predictor in the literature for N-terminalsorting signals. One drawback of neural networks, however, is that it is generally difficult to understand and interpret how and why they make such predictions. In this paper, we aim to generate simple and interpretable rules as predictors, and still achieve a practical prediction accuracy. We adopt an approach which consists of an extensive search for simple rules and various attributes which is partially guided by human intuition. Results: We have succeeded in finding rules whose prediction accuracies come close to that of TargetP, while still retaining a very simple and interpretable form. We also discuss and interpret the discovered rules. Availability: An (experimental) web service usingrules obtained by our method is provided at http://hypothesiscreator.net/iPSORT/. Contact: bannai@ims.u-tokyo.ac.jp

27 September 2003 in Bioinformatics
Verified
Journal Article
Open access
PDF file
YTYoshinori Tamada
Yoshinori Tamada
SKSunYong Kim
SunYong Kim
HBHideo Bannai
Hideo Bannai
SISeiya Imoto
Seiya Imoto
KTKousuke Tashiro
Kousuke Tashiro
SMSatoru Miyano
Satoru Miyano
We present a statistical method for estimating gene networks and detecting promoter elements simultaneously. When estimating a network from gene expression data alone, a common problem is that the number of microarrays is limited compared to the number of variables in the network model, making accurate estimation a difficult task. Our method overcomes this problem by integrating the microarray gene expression data and the DNA sequence information into a Bayesian network model. The basic idea of our method is that, if a parent gene is a transcription factor, its children may share a consensus motif in their promoter regions of the DNA sequences. Our method detects consensus motifs based on the structure of the estimated network, then re-estimates the network using the result of the motif detection. We continue this iteration until the network becomes stable. To show the effectiveness of our method, we conducted Monte Carlo simulations and applied our method to Saccharomyces cerevisiae data as a real application. Contact: tamada@ims.u-tokyo.ac.jp

1 September 2020 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
EUEiichiro Uchino
Eiichiro Uchino
KSKanata Suzuki
Kanata Suzuki
NSNoriaki Sato
Noriaki Sato
RKRyosuke Kojima
Ryosuke Kojima
YTYoshinori Tamada
Yoshinori Tamada
YOYasushi Okuno
Yasushi Okuno

24 November 2011 in Nucleic Acids Research
Verified
Journal Article
Open access
DHDaniel Hurley
Daniel Hurley
HAHiromitsu Araki
Hiromitsu Araki
YTYoshinori Tamada
Yoshinori Tamada
BDBen Dunmore
Ben Dunmore
DSDeborah Sanders
Deborah Sanders
CPCristin Print
Cristin Print
Gene regulatory networks inferred from RNA abundance data have generated significant interest, but despite this, gene network approaches are used infrequently and often require input from bioinformaticians. We have assembled a suite of tools for analysing regulatory networks, and we illustrate their use with microarray datasets generated in human endothelial cells. We infer a range of regulatory networks, and based on this analysis discuss the strengths and limitations of network inference from RNA abundance data. We welcome contact from researchers interested in using our inference and visualization tools to answer biological questions.

19 August 2010 in IEEE/ACM Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
YTYoshinori Tamada
Yoshinori Tamada
SISeiya Imoto
Seiya Imoto
HAHiromitsu Araki
Hiromitsu Araki
MNMasao Nagasaki
Masao Nagasaki
CPCristin Print
Cristin Print
SMSatoru Miyano
Satoru Miyano
We present a novel algorithm to estimate genome-wide gene networks consisting of more than 20,000 genes from gene expression data using nonparametric Bayesian networks. Due to the difficulty of learning Bayesian network structures, existing algorithms cannot be applied to more than a few thousand genes. Our algorithm overcomes this limitation by repeatedly estimating subnetworks in parallel for genes selected by neighbor node sampling. Through numerical simulation, we confirmed that our algorithm outperformed a heuristic algorithm in a shorter time. We applied our algorithm to microarray data from human umbilical vein endothelial cells (HUVECs) treated with siRNAs, to construct a human genome-wide gene network, which we compared to a small gene network estimated for the genes extracted using a traditional bioinformatics method. The results showed that our genome-wide gene network contains many features of the small network, as well as others that could not be captured during the small network estimation. The results also revealed master-regulator genes that are not in the small network but that control many of the genes in the small network. These analyses were impossible to realize without our proposed algorithm.

20 April 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LWLi Wang
Li Wang
DHDaniel G. Hurley
Daniel G. Hurley
WWWendy Watkins
Wendy Watkins
HAHiromitsu Araki
Hiromitsu Araki
YTYoshinori Tamada
Yoshinori Tamada
CPCristin Print
Cristin Print
Our understanding of the molecular pathways that underlie melanoma remains incomplete. Although several published microarray studies of clinical melanomas have provided valuable information, we found only limited concordance between these studies. Therefore, we took an in vitro functional genomics approach to understand melanoma molecular pathways. Affymetrix microarray data were generated from A375 melanoma cells treated in vitro with siRNAs against 45 transcription factors and signaling molecules. Analysis of this data using unsupervised hierarchical clustering and Bayesian gene networks identified proliferation-association RNA clusters, which were co-ordinately expressed across the A375 cells and also across melanomas from patients. The abundance in metastatic melanomas of these cellular proliferation clusters and their putative upstream regulators was significantly associated with patient prognosis. An 8-gene classifier derived from gene network hub genes correctly classified the prognosis of 23/26 metastatic melanoma patients in a cross-validation study. Unlike the RNA clusters associated with cellular proliferation described above, co-ordinately expressed RNA clusters associated with immune response were clearly identified across melanoma tumours from patients but not across the siRNA-treated A375 cells, in which immune responses are not active. Three uncharacterised genes, which the gene networks predicted to be upstream of apoptosis- or cellular proliferation-associated RNAs, were found to significantly alter apoptosis and cell number when over-expressed in vitro. This analysis identified co-expression of RNAs that encode functionally-related proteins, in particular, proliferation-associated RNA clusters that are linked to melanoma patient prognosis. Our analysis suggests that A375 cells in vitro may be valid models in which to study the gene expression modules that underlie some melanoma biological processes (e.g., proliferation) but not others (e.g., immune response). The gene expression modules identified here, and the RNAs predicted by Bayesian network inference to be upstream of these modules, are potential prognostic biomarkers and drug targets.